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Identity 
Other names: MGC102688, MGC17037, SPA1 




History and nomenclature: SIPA1 gene, originally 
referred to as SPA-1, was first isolated in 1995 as the 
secondary response gene transcriptionally induced in 
the lymphoid cells by the stimulation with mitogenic 
cytokines or cross-linking antigen receptors. 
Description 
The SIPA1 gene spans 12.8 kb of the genome and is 
characterized by 16 exons; exon 1, 91 bp of exon 2 a d 
the 3' 205 bp of exon 16 are untranslated. The figure 
shows the general structure of the gene. 
Transcription 
A 3.6 kb transcript is detected preferentially in 
lymphohematopoietic tissues and certain cancer cells. 
Two alternatively spliced variants encoding the same 




The SIPA1 protein, SPA-1, contains 1042 amino-acids 
(130 KDa); contains Rap GTPase-activating (GAP) 
domain (350-539), PDZ domain (685-759) and leucine 
zipper like domain (964-1042) which resembles myosin 
tail. 
Expression 
SPA-1 is most abundantly expressed in 
lymphohematopoietic tissues including bone marrow, 
thymus and spleen. 
Localisation 
Localized in various intracellular compartments, such 
as actin cytoskeleton, plasma membranes, and possibly 
nuclei, depending on the cell type and specific protein 
interaction via the PDZ domain. 
Function 
SPA-1 exhibits a specific GAP activity for Ras-relat d 
regulatory proteins Rap1 and Rap2, but not for Ran or 
other small GTPases. SPA-1 overexpression 
(abrogating the endogenous Rap1 activation) induced 
rounding and eventual detachment of inherently 
adherent cells from extra- 
 
Structure of the SIPA1 gene. 
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cellular matrix, indicating that Rap1 signals are 
involved in the regulation of cell adhesion and SPA-1 
functions as a negative regulator of cell adhesion. 
Homology 
SPA-1 is highly homologous to human rap1GAPs 
(RapGA1, RapGA2) at a catalytic domain called the 
GAP-related domain (GRD) (43% identical amino 
acids). So far, three homologous molecules of SPA-1 
except human rap1GAPs have been reported; SPA-1-
like (SPA-L1) (also called E6TP1 or SPAR), SPA-L2, 
and SPA-L3, all of which share a PDZ domain in 
addition to a GRD. 
Mutations 
Note 
SPA-1-deficient (Spa-1-/-) mice also develop age-
dependent progression of T-cell unresponsiveness, 
preceding the overt development of leukemia described 
as follows. Such Spa-1-/- T cells show defective Ras-
mediated ERK activation in response to TCR-
stimulation. Stimulation of the Spa-1-/- T cells by TCRs 
results in the persistence of a high level of Rap1 
activation.  
Spa-1-/- mice exhibit increased basal Rap1GTP 
selectively in the progenitor population of bone marrow 
cells, and this is associated with a progressive increase 
in the hematopoietic stem-cell population as the mice 
aged. After a long latent period, virtually all of the Spa-
1-/- mice develop overt leukemia, which can be 
classified into several distinct types. A proportion f 
them show a marked increase in the number of blood 
leukocytes with only a few blast cells, extensive 
enlargement of the liver and spleen, and hypercellular 
bone marrow. The increased leukocytes are 
predominantly mature granulocytes, or small lymphoid 
cells bearing an IgM+ CD5+ CD11b+ phenotype with 
monoclonal immunoglobulin gene-rearrangement 
patterns, closely resembling human chronic 
myelogenous leukemia (CML) in the chronic phase, or 
chronic lymphocytic leukemia (CLL), respectively. 
Both types of disease can be successfully transferred 
into severe combined immunodeficient (SCID) mice, 
indicating that the abnormal proliferation is myeloid 
progenitor cell autonomous. A minor portion of Spa-1-/- 
mice show decreased leukocyte numbers with 
dysplastic myeloid cells accompanied by severe 
anemia, being reminiscent of the human 
myelodysplatic syndrome (MDS).  
Finally, the majority of Spa-1-/- mice develop 
aggressive lethal leukemia with abundant blast cells of 
either myeloid or erythroid lineage, which extensively 
infiltrate into all the vital organs, probably reprsenting 
the blast crisis of CML in the chronic phase. Blast 
crisis represents a blastic transformation of leukemia 
cells that invariably  
occurs in the course of human CML, and is associated 
with signs and symptoms of acute leukemia, often with 
extramedullary disease. 
In addition to CML-like leukemia, around 15% of over 
100 Spa-1-/- mice developed B-lineage cell leukemia. 
The majority of B220+ leukemic cells exhibited CD5 
and Mac1 expression, apparently corresponding to B1 
cells. Indeed, the majority of Spa-1-/- mice show a 
progressive increase in their B1 cell populations in the 
peritoneal cavity as they aged; this was associated with 
the generation of anti-dsDNA antibody and lupus-like 
glomeluronephritis. Many of the Spa-1-/- mice with B1 
cell-type leukemia also show a hemolytic autoantibody; 
this feature highly resembled human B cell chronic 
lymphocytic leukemia (CLL).  
Sipa1 is a candidate gene for the Mtes-1 locus which is 
involved in controlling lung metastasis of mammary 
tumors in mouse model. In mice, there is a 
nonsynonymous polymorphism in the Sipa1, either 
alanine (A) or threonine (T) at the amino acid positi n 
741 in the PDZ domain; all the strains with a 
Sipa1/741A allele showed high metastatic tendency, 
whereas those with a Sipa1/741T allele reveal less lung 
metastasis. Sipa1/741A shows higher Rap1GAP 
activity than Sipa1/741T in cancer cells, probably due 
to the altered binding affinity of the PDZ domain for 
the interacting proteins. In agreement, overexpression 
of wild type Sipa1 in mammary tumor cells markedly 
enhanced the lung metastatic activity, whereas 
knockdown of the endogenous Sipa1 reduces the 
activity.  





Several studies have shown that germline 
polymorphisms in SIPA1 are associated with metastasis 
of breast cancer (Crawford et al., 2006; Hsieh et al., 
2009). Crawford et al. examined three SNPs within 
SIPA1 (one within the promoter (-313G>A: rs931127) 
and two exonic (545C>T: rs3741378 and 2760G>A: 
rs746429)). The population (n=300) consisted of 
randomly selected non-Hispanic Caucasian breast 
cancer patients using SNP-specfic PCR. They showed 
that the variant 2760G>A and the -313G>A allele were 
associated with lymp node involvement (P=0.0062 and 
P=0.0083, respectively), and the variant 545C>T was
associated with estrogen receptor negative tumors 
(P=0.0012) and with progesterone negative tumors 
(P=0.0339). Associations were identified between 
haplotypes defined by the three SNPs and disease 
progression. Correlation of SIPA1 SNP rs3741378 with 
breast cancer susceptibility was also confirmed by 
Hsieh et al. 
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